How much is Nuvalent worth in 2026?

Nuvalent has a current valuation of N/A based on their Early Stage VC (Series B) round and secondary market data.

How much funding has Nuvalent raised?

Nuvalent has raised N/A in total funding across 1 funding rounds.

Nuvalent

Drug Discovery

Nuvalent valuation and funding history | Last updated: May 11, 2021 | 1 funding rounds

Current Valuation

N/A

As of May 11, 2021

Total Funding Raised

N/A

Across 1 round

Last Round

Early Stage VC (Series B)

$135.0M

Last Funding

May 2021

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
May 11, 2021	Early Stage VC (Series B)	$135.0M	N/A	-

Valuation Analysis

Current Valuation Metrics

Nuvalent is currently valued at N/A as of May 11, 2021.

Track Nuvalent Valuation Updates

Get notified when Nuvalent raises new funding or valuation changes

Explore More Data

Detailed analysis for Nuvalent

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Nuvalent's valuation history, funding rounds, and growth metrics.

No credit card required

What is Nuvalent Worth in 2026?

Nuvalent is a leading private company in the Drug Discovery sector. Track Nuvalent's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Nuvalent Valuation is Determined

Private company valuations like Nuvalent's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.